Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,078 | 147 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $651.04 | 6 | $0 (2024) |
| Novo Nordisk Inc | $447.45 | 24 | $0 (2024) |
| Lilly USA, LLC | $323.54 | 20 | $0 (2024) |
| ABBVIE INC. | $218.07 | 17 | $0 (2024) |
| PFIZER INC. | $146.33 | 7 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $140.53 | 8 | $0 (2024) |
| Amarin Pharma Inc. | $137.59 | 8 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $136.16 | 7 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $105.20 | 5 | $0 (2023) |
| Amgen Inc. | $76.45 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,117 | 36 | Medtronic, Inc. ($651.04) |
| 2023 | $452.91 | 26 | Lilly USA, LLC ($76.84) |
| 2022 | $600.88 | 30 | Novo Nordisk Inc ($224.19) |
| 2021 | $907.93 | 55 | Amarin Pharma Inc. ($137.59) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $152.36 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Obesity | ||||||
| 10/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Oncology | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Hepatitis B Vaccine | ||||||
| 08/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $118.05 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Diabetes | ||||||
| 07/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Diabetes Care | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Narcoplepsy | ||||||
| 05/20/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Obesity | ||||||
| 05/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $153.78 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/02/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 04/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Obesity | ||||||
| 03/20/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 464 | 588 | $76,189 | $27,196 |
| 2022 | 9 | 397 | 588 | $60,823 | $24,469 |
| 2021 | 7 | 294 | 352 | $40,051 | $16,072 |
| 2020 | 8 | 370 | 466 | $49,968 | $16,293 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 175 | $37,910 | $12,528 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 58 | 58 | $14,625 | $6,432 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 85 | $12,308 | $4,066 | 33.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 114 | 162 | $3,078 | $1,361 | 44.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 17 | $1,615 | $1,223 | 75.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,707 | $824.87 | 17.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $836.00 | $548.53 | 65.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 14 | $758.00 | $116.39 | 15.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 34 | 44 | $352.00 | $96.80 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 149 | $28,757 | $10,480 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 52 | 52 | $11,908 | $5,866 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 104 | $13,520 | $5,598 | 41.4% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 11 | 11 | $2,750 | $1,550 | 56.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $704.00 | $434.72 | 61.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 65 | 83 | $1,577 | $245.64 | 15.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 23 | $1,127 | $217.07 | 19.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 27 | 30 | $240.00 | $66.66 | 27.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 11 | 120 | $240.00 | $10.71 | 4.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 102 | $19,176 | $7,099 | 37.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 87 | $11,136 | $4,651 | 41.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 28 | 28 | $6,412 | $3,104 | 48.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 11 | 11 | $1,045 | $717.86 | 68.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 61 | 78 | $1,482 | $234.00 | 15.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $528.00 | $188.88 | 35.8% |
| 81003 | Automated urinalysis test | Office | 2021 | 29 | 34 | $272.00 | $76.50 | 28.1% |
About Dena Patel, FNP
Dena Patel, FNP is a Family healthcare provider based in Buford, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2018. The National Provider Identifier (NPI) number assigned to this provider is 1881188951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dena Patel, FNP has received a total of $3,078 in payments from pharmaceutical and medical device companies, with $1,117 received in 2024. These payments were reported across 147 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,078).
As a Medicare-enrolled provider, Patel has provided services to 1,525 Medicare beneficiaries, totaling 1,994 services with total Medicare billing of $84,029. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Buford, GA
- Active Since 06/21/2018
- Last Updated 06/21/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1881188951
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $624.35
- Rybelsus (Drug) $187.52
- Vascepa (Drug) $137.59
- Ozempic (Drug) $130.32
- VRAYLAR (Drug) $126.30
- MOUNJARO (Drug) $112.97
- QELBREE (Drug) $105.20
- JARDIANCE (Drug) $98.00
- SPRAVATO (Drug) $91.77
- TRINTELLIX (Drug) $88.46
- Wegovy (Drug) $85.78
- ZEPBOUND (Drug) $73.38
- FREESTYLE LIBRE 3 (Device) $72.79
- Dexcom G6 Transmitter (Medical Supply) $71.12
- UBRELVY (Drug) $69.83
- PREVNAR 13 (Biological) $64.37
- EMGALITY (Drug) $64.33
- Aimovig (Biological) $58.79
- VYVANSE (Drug) $52.07
- Dayvigo (Drug) $49.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Buford
Han Bi Hong
Family — Payments: $9,513
Dr. Christian Gibbs, Dnp, Fnp-C, DNP, FNP-C
Family — Payments: $7,486
Dr. Helen Heiskell, Np, NP
Family — Payments: $4,473
Lucy Sorto, Np, NP
Family — Payments: $4,417
Joslin John, Fnp, FNP
Family — Payments: $2,624
Hiroyuki Tada
Family — Payments: $2,496